Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.
OBESITY RESEARCH SOLUTIONS(±)-Synephrine is an alkaloid with vasoconstrictor and metabolic activities.1,2,3 It binds to α1A-, α2A-, and α2C-adrenergic receptors (ARs; Kis = 78, 36.7, and 24.4 µM, respectively).4 (±)-Synephrine is an agonist of α1A-ARs in HEK293 cells (EC50 = 4 µM in a reporter assay) but not in CHO cells expressing α2A- or α2C-AR. It also acts as an antagonist of α1A-, α2A-, and α2C-ARs, inhibiting L-phenylephrine-induced activation of α1A-AR in HEK293 cells and activation of α2A- and α2C-ARs induced by the α2-AR agonist medetomidine in CHO cells (IC50s = 12.8, 26, and 27.3 µM, respectively, in reporter assays). (±)-Synephrine induces contractions in isolated rabbit aortic rings (EC50 = 6.2 µg/ml) and increases ligation-induced mean arterial pressure in rats when administered at a dose of 2 mg/kg per day.1,5 It induces lipolysis in isolated rat and human adipocytes when used at concentrations of 100 and 1,000 µg/ml.2 (±)-Synephrine (50 µM) increases phosphorylation of Akt and AMP-activated protein kinase (AMPK) and translocation of Glut4 to the plasma membrane, as well as increases insulin-induced glucose consumption in L6 muscle cells when used at concentrations ranging from 25 to 200 µM.3
WARNING This product is not for human or veterinary use.
1. Fructus aurantii reduced portal pressure in portal hypertensive rats. Life Sci. 57(22), 2011-2020 (1995).
2. Isopropylnorsynephrine is a stronger lipolytic agent in human adipocytes than synephrine and other amines present in Citrus aurantium. J. Physiol. Biochem. 67(3), 443-452 (2011).
3. p-
4. Effects of synephrine and β-
5. Relative sensitivity of some large blood vessels of the rabbit to sympathomimetic amines. J. Pharmacol. Exp. Ther. 150(3), 370-374 (1965).